Literature DB >> 25734214

The expanding field of platelet-bacterial interconnections.

Steven W Kerrigan1.   

Abstract

Given their small size, platelets are emerging as being one of the most important entities in the bloodstream. Not only do they play a key role in maintaining thrombosis and haemostasis, platelets also play a critical role in orchestrating the immune response. Being the first cell at the site of injury, they are perfectly placed to assess the extent of the damage and recruit immune cells as is necessary. As a first line of defence, platelets can act as primitive immune cells themselves by interacting with invading pathogens. A number of platelet receptors have been shown to interact with bacteria either directly or indirectly, involving a plasma protein bridge. This review will discuss the molecular mechanisms that exist between platelets and bacteria and the functional response to the interaction. We will also discuss the importance of considering animal models of disease and the use of physiological shear when studying platelet-bacterial interactions.

Entities:  

Keywords:  Bacteria; Staphylococcus; Streptococcus; immune; infection; platelets

Mesh:

Year:  2015        PMID: 25734214     DOI: 10.3109/09537104.2014.997690

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  19 in total

1.  Getting to the heart of the matter: Role of Streptococcus mutans adhesin Cnm in systemic disease.

Authors:  Angela Nobbs
Journal:  Virulence       Date:  2016-07-13       Impact factor: 5.882

Review 2.  Coordinated Molecular Cross-Talk between Staphylococcus aureus, Endothelial Cells and Platelets in Bloodstream Infection.

Authors:  Carolina D Garciarena; Tony M McHale; Rebecca L Watkin; Steven W Kerrigan
Journal:  Pathogens       Date:  2015-12-05

3.  Interaction of Treponema pallidum, the syphilis spirochete, with human platelets.

Authors:  Brigette Church; Erika Wall; John R Webb; Caroline E Cameron
Journal:  PLoS One       Date:  2019-01-18       Impact factor: 3.240

4.  Recognition of specific sialoglycan structures by oral streptococci impacts the severity of endocardial infection.

Authors:  Barbara A Bensing; Liang Li; Olga Yakovenko; Maurice Wong; Karen N Barnard; T M Iverson; Carlito B Lebrilla; Colin R Parrish; Wendy E Thomas; Yan Xiong; Paul M Sullam
Journal:  PLoS Pathog       Date:  2019-06-24       Impact factor: 6.823

5.  The Dynamics of Platelet Activation during the Progression of Streptococcal Sepsis.

Authors:  Sinead M Hurley; Nataliya Lutay; Bo Holmqvist; Oonagh Shannon
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

6.  Human platelet activation by Escherichia coli: roles for FcγRIIA and integrin αIIbβ3.

Authors:  Callum N Watson; Steven W Kerrigan; Dermot Cox; Ian R Henderson; Steve P Watson; Mònica Arman
Journal:  Platelets       Date:  2016-03-30       Impact factor: 3.862

Review 7.  Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critically [corrected] ill patients?

Authors:  Antoine Dewitte; Sébastien Lepreux; Julien Villeneuve; Claire Rigothier; Christian Combe; Alexandre Ouattara; Jean Ripoche
Journal:  Ann Intensive Care       Date:  2017-12-01       Impact factor: 6.925

8.  Concerted functions of Streptococcus gordonii surface proteins PadA and Hsa mediate activation of human platelets and interactions with extracellular matrix.

Authors:  Jennifer A Haworth; Howard F Jenkinson; Helen J Petersen; Catherine R Back; Jane L Brittan; Steve W Kerrigan; Angela H Nobbs
Journal:  Cell Microbiol       Date:  2016-10-11       Impact factor: 3.715

9.  CXCL4 contributes to host defense against acute Pseudomonas aeruginosa lung infection.

Authors:  Lei Yue; Zheng Pang; Hua Li; Ting Yang; Lei Guo; Longding Liu; Junjie Mei; Xia Song; Tianhong Xie; Ye Zhang; Xin He; Tong-Jun Lin; Zhongping Xie
Journal:  PLoS One       Date:  2018-10-08       Impact factor: 3.240

10.  Platelet reactivity in diabetic patients with invasive Klebsiella pneumoniae liver abscess syndrome.

Authors:  Chen-Hsiang Lee; Seng-Kee Chuah; Wei-Chen Tai; I-Ling Chen
Journal:  Infect Drug Resist       Date:  2018-10-09       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.